Practice

Dr. John Cush Tweet
@RheumNow
RheumNow’s expanded coverage of #ACR26 annual meeting is sponsored by Eli Lilly and Company. All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush Tweet
@RheumNow
RheumNow’s expanded coverage of the #ACR26 Annual Meeting is sponsored by UCB. All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush Tweet
@RheumNow
GCA with normal CRP? French study of GCA > 50 yrs, dx w/ temp artery Bx 67% or imaging (US, PET) + nl Baseline CRP <10 mg/L. 74 pts (age 73 yrs) 84% filled 2022 Dx criteria. Low CRP pt had less fever, fatigue, wt loss, PMR Sxs & more ischemic Sxs and strokes. They were more https://t.co/olL8Vf93DW
anita Tweet
@docdhanrajani
@RheumNow Building bridges to better care: Advocacy and legislative updates in pediatrics #ACR2026 The AAP advocates for equitable access to care, science-based policies, fair reimbursement & pediatric workforce equity. Advocacy is stronger together!
Antoni Chan MD (Prof) Tweet
@synovialjoints
Five AI platforms were tested on 60 ACR and EULAR based scenarios: guideline concordance ranged from 74.9% to 91.2% and hallucination rates from 3.8% to 18.1%. Key finding: clinically relevant errors occurred on every platform, and the authors recommend clinician oversight.
Mrinalini Dey Tweet
@DrMiniDey
AI advice in clinical decision support still needs checking. In 60 rheum scenarios, 5 platforms had hallucination rates of 3.8-18.1%. Dosing, treatment-selection and screening errors occurred across platforms, even those with high guideline concordance. #0869 @Rheumnow #ACR26
Article

3 x IL-23 = IL do Better (11.6.2026)

Jack Cush, MD

Dr. Jack Cush reviews the FDA approvals and news reports from this past week on RheumNow.com. This week we discuss playing the numbers in rheumatology, playing the long game with stem cell transplants, and a=the Positive spin on seronegative RA. 

Article

The Concern about Seronegative RA

Jack Cush, MD

A current review of seronegative RA (SNRA) by D’Onofrio, et al in npj Autoimmunity shows the diverse fate of seronegative RA - which can resolve, persist or become refractory. Clearly dedicated trials of SNRA are needed to better predict.

Therapeutic Updates

Lupus Nephritis

Sponsored by RheumNow
Management of CKD in Lupus Nephritis Patients
View our six video perspectives on lupus nephritis, including Management of CKD in Lupus Nephritis.
Read Post

Podcasts

  • Better Gout Management

Topic Videos
×